Biotech
Arena Pharmaceuticals, Inc.
1
Articles
Mentioned
Top Role
Apr 9, 2026
First Mention
Apr 9, 2026
Last Mention
0.73
Relevance Score
Coverage Timeline
April 2026
Eli Lilly's $2.4 Billion DICE Therapeutics Bet: Pipeline Risk, Platform Ambition, and Autoimmune Expansion
Deals
Mentioned
Apr 9, 2026
You’d have to look back to the early JAK inhibitor wave, or Pfizer’s $2.1 billion play for Arena Pharmaceuticals, another bet on autoimmune innovation.